梅瓦科尔/聚乙/二乙基甲酸) 作为固体溶液:制备,提高溶解度和药物输送
Mohammed Alassaf1, Saad Mohammed Alqahtani1, Rana Salem Al Khulaifi1
1Department of Chemistry, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
Polymers
|October 14, 2023
概括
新的Mevacor (MVR) 药物载体系统,MVR/Poly (乙酸-co-2-基乙基甲酸) (VAC-HEMA),提供更好的溶解性和受控释放. 优化的MVR/VAC-HEMA配方显示出短期和长期胃肠道过境的前景.
科学领域:
- 聚合物科学 聚合物科学
- 材料科学 材料科学 材料科学
- 药物输送系统 药物输送系统
背景情况:
- 开发有效的药物输送系统对于改善治疗结果至关重要.
- 聚合物药物载体提供可调节的特性,用于控制药物释放.
- 梅瓦科尔 (MVR) 需要优化的输送策略来提高其溶解性和生物可用性.
研究的目的:
- 为了合成和描述Mevacor (MVR) 装载的聚乙酸-co-2-乙烯基甲基酸 (VAC-HEMA) 共聚合物药载体.
- 研究MVR含量和pH对MVR/VAC-HEMA系统的胀和药物释放特性的影响.
- 评估药物载体系统在不同胃肠道传输时间的体外性能.
主要方法:
- 乙乙烯酸和2-基乙基甲酸盐的自由基共聚合与Mevacor.
- 使用FTIR,1H NMR,DSC,SEM和XRD进行表征.
- 在不同的pH值下进行体外胀能力和药物释放研究.
主要成果:
- 梅瓦科尔颗粒均分散在共聚合物矩阵中,形成固体溶液.
- MVR/VAC-HEMA系统在MVR负载水平为0.25-2.00 wt%时没有显示显著的细胞毒性.
- 与免费药物相比,MVR的溶解性显著增加 (22-37倍),释放概况优化为短 (0.5 wt% MVR) 和长 (2.0 wt% MVR) 的胃肠道过渡.
结论:
- MVR/VAC-HEMA系统是一个有前途的,无毒的药物载体,具有增强的MVR溶解性和受控释放能力.
- 药物载体系统可以通过调整MVR内容来适应特定的胃肠道运输时间.
- 这种新型药物输送系统有可能提高Mevacor治疗效率.
更多相关视频
10:12Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
Published on: January 7, 2019
22.1K
05:08Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
Published on: September 20, 2017
16.8K
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
211
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
211
Factors Affecting Dissolution: Particle Size and Effective Surface Area
866
Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are...
866
